1. C5aR deficiency attenuates the breast cancer development via the p38/p21 axis
   Jian Chen et al, 2020, Aging CrossRef
2. Progress in Delivery of siRNA-Based Therapeutics Employing Nano-Vehicles for Treatment of Prostate Cancer
   Milad Ashrafizadeh et al, 2020, Bioengineering CrossRef
3. Decreased c-Abl activity in PC-3 and LNCaP prostate cancer cells overexpressing the early growth response-1 protein
   EDUARDO PARRA et al, 2014, Oncology Reports CrossRef
4. Anti-tumor activity of SL4 against breast cancer cells: induction of G2/M arrest through modulation of the MAPK-dependent p21 signaling pathway
   Li-Hui Wang et al, 2016, Scientific Reports CrossRef
5. JNK1 inhibitors target distal B cell receptor signaling and overcome BTK-inhibitor resistance in CLL
   Shifa Khaja Saleem et al, 2025, Journal of Experimental Medicine CrossRef
6. Association of increased levels of TGF-β1 and p14ARF in prostate carcinoma cell lines overexpressing Egr-1
   EDUARDO PARRA et al, 2014, Oncology Reports CrossRef
7. Increased expression of p21Waf1/Cip1 and JNK with costimulation of prostate cancer cell activation by an siRNA Egr-1 inhibitor
   EDUARDO PARRA et al, 2013, Oncology Reports CrossRef
8. Inhibition of basal JNK activity by small interfering RNAs enhances cisplatin sensitivity and decreases DNA repair in T98G glioblastoma cells
   EDUARDO PARRA et al, 2015, Oncology Reports CrossRef
9. Cancer/Testis Antigen PAGE4, a Regulator of c-Jun Transactivation, Is Phosphorylated by Homeodomain-Interacting Protein Kinase 1, a Component of the Stress-Response Pathway
   Steven M. Mooney et al, 2014, Biochemistry CrossRef